Guus M. Bol - Publications

Reply to "Reassessing the evidence for elevated deficient mismatch repair colorectal cancer risk after kidney transplantation".

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: April 25, 2026

The paradox of escalating immunotherapy for uveal melanoma liver metastases.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: April 22, 2026

Phase I Dose-Escalation Study Combining Irinotecan-Loaded Drug-Eluting Bead Chemoembolization with Yttrium-90 Glass Microspheres Radioembolization in Colorectal Liver Metastases (DEBIR90Y).

Journal: Journal of vascular and interventional radiology : JVIR

Published: March 10, 2026

A novel approach to radioembolization treatment planning using a hybrid [99mTc]Tc-MAA contrast enhanced SPECT/CT.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 26, 2026

Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC-ESTRO OligoCare consortium.

Journal: The Lancet. Oncology

Published: December 20, 2025

Tumor burden in metastatic colorectal cancer quantified using deep learning models: Prognostic value and maintenance treatment benefit in the CAIRO3 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 11, 2025

Can non-tumorous liver tissue serve as a reliable reference measure for [18F]FDG-PET-CT after unilobar 90Y glass radioembolization in patients with colorectal liver metastases?

Journal: EJNMMI research

Published: June 30, 2025

Clinical implications of whole genome sequencing in metastatic colorectal cancer.

Journal: Oncogene

Published: June 10, 2025

Risk of deficient mismatch repair colorectal cancer and precursors after kidney transplantation: A nationwide study.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: June 03, 2025

Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 18, 2025

Inhibition of DDX3 modulates immune signaling in aggressive breast cancers.

Journal: Cancer letters

Published: April 14, 2025

Impact of Tumor Size on Outcomes of Hepatic Arteriography and C-Arm CT-Guided Ablation (HepACAGA): > 3 cm Is No Absolute Contraindication.

Journal: Cardiovascular and interventional radiology

Published: April 01, 2025